Skip to main content

Welkom bij THIM Hogeschool voor Fysiotherapie & Bohn Stafleu van Loghum

THIM Hogeschool voor Fysiotherapie heeft ervoor gezorgd dat je Mijn BSL eenvoudig en snel kunt raadplegen. Je kunt je links eenvoudig registreren. Met deze gegevens kun je thuis, of waar ook ter wereld toegang krijgen tot Mijn BSL. Heb je een vraag, neem dan contact op met helpdesk@thim.nl.

Registreer

Om ook buiten de locaties van THIM, thuis bijvoorbeeld, van Mijn BSL gebruik te kunnen maken, moet je jezelf eenmalig registreren. Dit kan alleen vanaf een computer op een van de locaties van THIM.

Eenmaal geregistreerd kun je thuis of waar ook ter wereld onbeperkt toegang krijgen tot Mijn BSL.

Login

Als u al geregistreerd bent, hoeft u alleen maar in te loggen om onbeperkt toegang te krijgen tot Mijn BSL.

Top
Gepubliceerd in:

26-06-2017

Health-related quality of life as measured by the EQ-5D in the prevention, screening and management of cervical disease: A systematic review

Auteurs: A. Ó Céilleachair, J. F. O’Mahony, M. O’Connor, J. O’Leary, C. Normand, C. Martin, L. Sharp

Gepubliceerd in: Quality of Life Research | Uitgave 11/2017

Log in om toegang te krijgen
share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail

Abstract

Purpose

Cost-effectiveness analyses (CEAs) of screening can be highly sensitive to the health-related quality of life (HRQoL) effects of screen tests and subsequent treatment. Accordingly, accurate assessment of HRQoL is essential. We reviewed the literature regarding HRQoL in cervical prevention and management in order to appraise the current evidence regarding this important input to CEA.

Methods

We searched the MEDLINE, Scopus and EconLit databases for studies that estimated HRQoL in cervical cancer prevention and management published January 1995–December 2015. The primary inclusion criterion was for studies that assess HRQoL using the EQ-5D. Data were abstracted from eligible studies on setting, elicitation group, sample size, elicitation instruments, health state valuations, study design and follow-up. We assessed the quality and comparability of the studies with a particular focus on the HRQoL reported across states and groups.

Results

Fifteen papers met the inclusion criteria. Most used patient elicitation groups (n = 11), 2 used the general public and 2 used a mix of both. Eight studies were cross-sectional and seven were longitudinal. Six studies used both the EQ-5D-3L and the EQ-VAS together with other measures of overall HRQoL or condition-specific instruments. Extensive heterogeneity was observed across study characteristics.

Conclusions

Our results reveal the challenges of sourcing reliable estimates of HRQoL for use in CEAs of cervical cancer prevention and treatment. The EQ-5D appears insufficiently sensitive for some health states. A more general problem is the paucity of HRQoL estimates for many health states and their change over time.
Bijlagen
Alleen toegankelijk voor geautoriseerde gebruikers
Voetnoten
1
Most VAS, including the EQ-VAS run from 0 to 100.
 
Literatuur
1.
go back to reference Bray, F., Ren, J.-S., Masuyer, E., & Ferlay, J. (2013). Global estimates of cancer prevalence for 27 sites in the adult population in 2008. International Journal of Cancer, 132(5), 1133–1145. doi:10.1002/ijc.27711.CrossRefPubMed Bray, F., Ren, J.-S., Masuyer, E., & Ferlay, J. (2013). Global estimates of cancer prevalence for 27 sites in the adult population in 2008. International Journal of Cancer, 132(5), 1133–1145. doi:10.​1002/​ijc.​27711.CrossRefPubMed
2.
go back to reference International Agency for Research on Cancer. (2005). IARC Handbooks of Cancer Prevention Vol. 10: Cervix Cancer Screening (p. 313). Lyons. International Agency for Research on Cancer. (2005). IARC Handbooks of Cancer Prevention Vol. 10: Cervix Cancer Screening (p. 313). Lyons.
5.
go back to reference Arbyn, M., De Sanjosé, S., Saraiya, M., Sideri, M., Palefsky, J., Lacey, C., et al. (2012). EUROGIN 2011 roadmap on prevention and treatment of HPV-related disease. International Journal of Cancer, 131(9), 1969–1982.CrossRefPubMedPubMedCentral Arbyn, M., De Sanjosé, S., Saraiya, M., Sideri, M., Palefsky, J., Lacey, C., et al. (2012). EUROGIN 2011 roadmap on prevention and treatment of HPV-related disease. International Journal of Cancer, 131(9), 1969–1982.CrossRefPubMedPubMedCentral
6.
go back to reference Bhatia, R., Kavanagh, K., Cubie, H. A., Serrano, I., Wennington, H., Hopkins, M., et al. (2016). Use of HPV testing for cervical screening in vaccinated women-Insights from the SHEVa (Scottish HPV Prevalence in Vaccinated Women) study: Use of HPV Testing for Cervical Screening. International Journal of Cancer, 138(12), 2922–2931. doi:10.1002/ijc.30030.CrossRefPubMed Bhatia, R., Kavanagh, K., Cubie, H. A., Serrano, I., Wennington, H., Hopkins, M., et al. (2016). Use of HPV testing for cervical screening in vaccinated women-Insights from the SHEVa (Scottish HPV Prevalence in Vaccinated Women) study: Use of HPV Testing for Cervical Screening. International Journal of Cancer, 138(12), 2922–2931. doi:10.​1002/​ijc.​30030.CrossRefPubMed
7.
go back to reference Guan, P., Howell-Jones, R., Li, N., Bruni, L., de Sanjosé, S., Franceschi, S., et al. (2012). Human papillomavirus types in 115,789 HPV-positive women: a meta-analysis from cervical infection to cancer. International Journal of Cancer, 131(10), 2349–2359. doi:10.1002/ijc.27485.CrossRefPubMed Guan, P., Howell-Jones, R., Li, N., Bruni, L., de Sanjosé, S., Franceschi, S., et al. (2012). Human papillomavirus types in 115,789 HPV-positive women: a meta-analysis from cervical infection to cancer. International Journal of Cancer, 131(10), 2349–2359. doi:10.​1002/​ijc.​27485.CrossRefPubMed
8.
go back to reference Lehtinen, M., Paavonen, J., Wheeler, C. M., Jaisamrarn, U., Garland, S. M., Castellsagué, X., … HPV PATRICIA Study Group. (2012). Overall efficacy of HPV-16/18 AS04-adjuvanted vaccine against grade 3 or greater cervical intraepithelial neoplasia: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial. The lancet Oncology, 13(1), 89–99. doi:10.1016/S1470-2045(11)70286-8.CrossRef Lehtinen, M., Paavonen, J., Wheeler, C. M., Jaisamrarn, U., Garland, S. M., Castellsagué, X., … HPV PATRICIA Study Group. (2012). Overall efficacy of HPV-16/18 AS04-adjuvanted vaccine against grade 3 or greater cervical intraepithelial neoplasia: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial. The lancet Oncology, 13(1), 89–99. doi:10.​1016/​S1470-2045(11)70286-8.CrossRef
9.
go back to reference Brotherton, J. M., Fridman, M., May, C. L., Chappell, G., Saville, A. M., & Gertig, D. M. (2011). Early effect of the HPV vaccination programme on cervical abnormalities in Victoria, Australia: an ecological study. The Lancet, 377(9783), 2085–2092. doi:10.1016/S0140-6736(11)60551-5.CrossRef Brotherton, J. M., Fridman, M., May, C. L., Chappell, G., Saville, A. M., & Gertig, D. M. (2011). Early effect of the HPV vaccination programme on cervical abnormalities in Victoria, Australia: an ecological study. The Lancet, 377(9783), 2085–2092. doi:10.​1016/​S0140-6736(11)60551-5.CrossRef
10.
go back to reference Palmer, T. J., McFadden, M., Pollock, K. G. J., Kavanagh, K., Cuschieri, K., Cruickshank, M., et al. (2016). HPV immunisation and cervical screening—confirmation of changed performance of cytology as a screening test in immunised women: a retrospective population-based cohort study. British Journal of Cancer, 114(5), 582–589. doi:10.1038/bjc.2015.474.CrossRefPubMedPubMedCentral Palmer, T. J., McFadden, M., Pollock, K. G. J., Kavanagh, K., Cuschieri, K., Cruickshank, M., et al. (2016). HPV immunisation and cervical screening—confirmation of changed performance of cytology as a screening test in immunised women: a retrospective population-based cohort study. British Journal of Cancer, 114(5), 582–589. doi:10.​1038/​bjc.​2015.​474.CrossRefPubMedPubMedCentral
11.
go back to reference Palmer, T. J., McFadden, M., Pollock, K. G. J., Kavanagh, K., Cuschieri, K., Cruickshank, M., et al. (2016). HPV immunisation and increased uptake of cervical screening in Scottish women; observational study of routinely collected national data. British Journal of Cancer, 114(5), 576–581. doi:10.1038/bjc.2015.473.CrossRefPubMedPubMedCentral Palmer, T. J., McFadden, M., Pollock, K. G. J., Kavanagh, K., Cuschieri, K., Cruickshank, M., et al. (2016). HPV immunisation and increased uptake of cervical screening in Scottish women; observational study of routinely collected national data. British Journal of Cancer, 114(5), 576–581. doi:10.​1038/​bjc.​2015.​473.CrossRefPubMedPubMedCentral
12.
go back to reference Kim, J. J., Wright, T. C., & Goldie, S. J. (2002). Cost-effectiveness of alternative triage strategies for atypical squamous cells of undetermined significance. JAMA, 287(18), 2382–2390.CrossRefPubMed Kim, J. J., Wright, T. C., & Goldie, S. J. (2002). Cost-effectiveness of alternative triage strategies for atypical squamous cells of undetermined significance. JAMA, 287(18), 2382–2390.CrossRefPubMed
14.
go back to reference Health Information and Quality Authority. (2014). Guidelines for the Economic Evaluation of Health Technologies in Ireland (Guidelines). Dublin, Ireland: Health Information and Quality Authority. Retrieved from https://www.google.ie/url?sa=t&rct=j&q=&esrc=s&source=web&cd=2&ved=0ahUKEwiT8uqqqM7QAhWpIMAKHT4aAxoQFggfMAE&url=https%3A%2F%2Fwww.hiqa.ie%2Fsystem%2Ffiles%2FHTA_Economic_Guidelines_2010.pdf&usg=AFQjCNGFcHjU2xjrOfE6hC4Ocqpv_AhxYw&sig2=AmhXqI0IR-pmO_TeHmU4aw Health Information and Quality Authority. (2014). Guidelines for the Economic Evaluation of Health Technologies in Ireland (Guidelines). Dublin, Ireland: Health Information and Quality Authority. Retrieved from https://​www.​google.​ie/​url?​sa=​t&​rct=​j&​q=​&​esrc=​s&​source=​web&​cd=​2&​ved=​0ahUKEwiT8uqqqM7​QAhWpIMAKHT4aAxo​QFggfMAE&​url=​https%3A%2F%2Fwww.hiqa.ie%2Fsystem%2Ffiles%2FHTA_Economic_Guidelines_2010.pdf&usg=AFQjCNGFcHjU2xjrOfE6hC4Ocqpv_AhxYw&sig2=AmhXqI0IR-pmO_TeHmU4aw
15.
go back to reference Rabin, R., & de Charro, F. (2001). EQ-5D: a measure of health status from the EuroQol Group. Annals of Medicine, 33, 337–343.CrossRefPubMed Rabin, R., & de Charro, F. (2001). EQ-5D: a measure of health status from the EuroQol Group. Annals of Medicine, 33, 337–343.CrossRefPubMed
18.
go back to reference Kavanagh, A. M., & Broom, D. H. (1997). Women’s understanding of abnormal cervical smear test results: a qualitative interview study. BMJ (Clinical research ed.), 314(7091), 1388–1391.CrossRef Kavanagh, A. M., & Broom, D. H. (1997). Women’s understanding of abnormal cervical smear test results: a qualitative interview study. BMJ (Clinical research ed.), 314(7091), 1388–1391.CrossRef
19.
20.
go back to reference O'Connor, M., Gallagher, P., Waller, J., Martin, C. M., O'Leary, J. J., Sharp, L., & Irish Cervical Screening Research Consortium (CERVIVA). (2016). Adverse psychological outcomes following colposcopy and related procedures: a systematic review. BJOG: An International Journal of Obstetrics & Gynaecology, 123(1), 24–38. doi:10.1111/1471-0528.13462.CrossRef O'Connor, M., Gallagher, P., Waller, J., Martin, C. M., O'Leary, J. J., Sharp, L., & Irish Cervical Screening Research Consortium (CERVIVA). (2016). Adverse psychological outcomes following colposcopy and related procedures: a systematic review. BJOG: An International Journal of Obstetrics & Gynaecology, 123(1), 24–38. doi:10.​1111/​1471-0528.​13462.CrossRef
21.
go back to reference Gold, M. R., Franks, P., McCoy, K. I., & Fryback, D. G. (1998). Toward consistency in cost-utility analyses: using national measures to create condition-specific values. Medical Care, 36(6), 778–792.CrossRefPubMed Gold, M. R., Franks, P., McCoy, K. I., & Fryback, D. G. (1998). Toward consistency in cost-utility analyses: using national measures to create condition-specific values. Medical Care, 36(6), 778–792.CrossRefPubMed
22.
go back to reference Myers, E., Green, S., & Lipkus, I. (2004). Patient preferences for health states related to HPV infection: visual analogue scales vs. time trade-off elicitation. In Proceedings of the 21st International Papillomavirus Conference. Presented at the 21st International Papillomavirus Conference, Mexico City. Myers, E., Green, S., & Lipkus, I. (2004). Patient preferences for health states related to HPV infection: visual analogue scales vs. time trade-off elicitation. In Proceedings of the 21st International Papillomavirus Conference. Presented at the 21st International Papillomavirus Conference, Mexico City.
23.
24.
go back to reference Neumann, P. J., Greenberg, D., Olchanski, N. V., Stone, P. W., & Rosen, A. B. (2005). Growth and quality of the cost-utility literature, 1976–2001. Value in Health: The Journal of the International Society for Pharmacoeconomics and Outcomes Research, 8(1), 3–9. doi:10.1111/j.1524-4733.2005.04010.x.CrossRef Neumann, P. J., Greenberg, D., Olchanski, N. V., Stone, P. W., & Rosen, A. B. (2005). Growth and quality of the cost-utility literature, 1976–2001. Value in Health: The Journal of the International Society for Pharmacoeconomics and Outcomes Research, 8(1), 3–9. doi:10.​1111/​j.​1524-4733.​2005.​04010.​x.CrossRef
25.
go back to reference UNDP. (2015). Work for human development. New York, NY: United Nations Development Programme. UNDP. (2015). Work for human development. New York, NY: United Nations Development Programme.
26.
go back to reference Vistad, I., Fosså, S. D., & Dahl, A. A. (2006). A critical review of patient-rated quality of life studies of long-term survivors of cervical cancer. Gynecologic Oncology, 102(3), 563–572.CrossRefPubMed Vistad, I., Fosså, S. D., & Dahl, A. A. (2006). A critical review of patient-rated quality of life studies of long-term survivors of cervical cancer. Gynecologic Oncology, 102(3), 563–572.CrossRefPubMed
27.
go back to reference Woodhall, S., Eriksson, T., Nykanen, A.-M., Huhtala, H., Rissanen, P., Apter, D., et al. (2011). Impact of HPV vaccination on young women’s quality of life - a five year follow-up study. The European journal of contraception & reproductive health care: the official journal of the European Society of Contraception, 16(1), 3–8.CrossRef Woodhall, S., Eriksson, T., Nykanen, A.-M., Huhtala, H., Rissanen, P., Apter, D., et al. (2011). Impact of HPV vaccination on young women’s quality of life - a five year follow-up study. The European journal of contraception & reproductive health care: the official journal of the European Society of Contraception, 16(1), 3–8.CrossRef
28.
go back to reference Eriksson, T., Torvinen, S., Woodhall, S. C., Lehtinen, M., Apter, D., Harjula, K., et al. (2013). Impact of HPV16/18 vaccination on quality of life: a pilot study. The European journal of contraception & reproductive health care: the official journal of the European Society of Contraception, 18(5), 364–371.CrossRef Eriksson, T., Torvinen, S., Woodhall, S. C., Lehtinen, M., Apter, D., Harjula, K., et al. (2013). Impact of HPV16/18 vaccination on quality of life: a pilot study. The European journal of contraception & reproductive health care: the official journal of the European Society of Contraception, 18(5), 364–371.CrossRef
29.
go back to reference Maissi, E., Marteau, T. M., Hankins, M., Moss, S., Legood, R., & Gray, A. (2005). The psychological impact of human papillomavirus testing in women with borderline or mildly dyskaryotic cervical smear test results: 6-month follow-up. British Journal of Cancer, 92(6), 990–994.CrossRefPubMedPubMedCentral Maissi, E., Marteau, T. M., Hankins, M., Moss, S., Legood, R., & Gray, A. (2005). The psychological impact of human papillomavirus testing in women with borderline or mildly dyskaryotic cervical smear test results: 6-month follow-up. British Journal of Cancer, 92(6), 990–994.CrossRefPubMedPubMedCentral
31.
go back to reference Pirotta, M., Ung, L., Stein, A., Conway, E. L., Mast, T. C., Fairley, C. K., et al. (2009). The psychosocial burden of human papillomavirus related disease and screening interventions. Sexually transmitted infections, 85(7), 508–513.CrossRefPubMed Pirotta, M., Ung, L., Stein, A., Conway, E. L., Mast, T. C., Fairley, C. K., et al. (2009). The psychosocial burden of human papillomavirus related disease and screening interventions. Sexually transmitted infections, 85(7), 508–513.CrossRefPubMed
32.
go back to reference Drolet, M., Brisson, M., Maunsell, E., Franco, E. L., Coutlee, F., Ferenczy, A., et al. (2012). The psychosocial impact of an abnormal cervical smear result. Psycho-oncology, 21(10), 1071–1081.CrossRefPubMed Drolet, M., Brisson, M., Maunsell, E., Franco, E. L., Coutlee, F., Ferenczy, A., et al. (2012). The psychosocial impact of an abnormal cervical smear result. Psycho-oncology, 21(10), 1071–1081.CrossRefPubMed
33.
go back to reference Korfage, I. J., van Ballegooijen, M., Wauben, B., Looman, C. W. N., Habbema, J. D. F., & Essink-Bot, M.-L. (2012). Having a Pap smear, quality of life before and after cervical screening: a questionnaire study. BJOG: an international journal of obstetrics and gynaecology, 119(8), 936–944.CrossRef Korfage, I. J., van Ballegooijen, M., Wauben, B., Looman, C. W. N., Habbema, J. D. F., & Essink-Bot, M.-L. (2012). Having a Pap smear, quality of life before and after cervical screening: a questionnaire study. BJOG: an international journal of obstetrics and gynaecology, 119(8), 936–944.CrossRef
35.
go back to reference Whynes, D. K., Woolley, C., Philips, Z., & Trial of Management of Borderline and Other Low-grade Abnormal smears Group. (2008). Management of low-grade cervical abnormalities detected at screening: which method do women prefer? Cytopathology: official journal of the British Society for Clinical Cytology, 19(6), 355–362.CrossRef Whynes, D. K., Woolley, C., Philips, Z., & Trial of Management of Borderline and Other Low-grade Abnormal smears Group. (2008). Management of low-grade cervical abnormalities detected at screening: which method do women prefer? Cytopathology: official journal of the British Society for Clinical Cytology, 19(6), 355–362.CrossRef
36.
go back to reference Galante, J., Augustovski, F., Colantonio, L., Bardach, A., Caporale, J., Marti, S. G., et al. (2011). Estimation and comparison of EQ-5D health states’ utility weights for pneumococcal and human papillomavirus diseases in Argentina, Chile, and the United Kingdom. Value in health: the journal of the International Society for Pharmacoeconomics and Outcomes Research, 14(5 Suppl 1), S60–S64.CrossRef Galante, J., Augustovski, F., Colantonio, L., Bardach, A., Caporale, J., Marti, S. G., et al. (2011). Estimation and comparison of EQ-5D health states’ utility weights for pneumococcal and human papillomavirus diseases in Argentina, Chile, and the United Kingdom. Value in health: the journal of the International Society for Pharmacoeconomics and Outcomes Research, 14(5 Suppl 1), S60–S64.CrossRef
37.
go back to reference Whynes, D. K. (2013). Does the correspondence between EQ-5D health state description and VAS score vary by medical condition? Health and quality of life outcomes, 11(101153626), 155.CrossRefPubMedPubMedCentral Whynes, D. K. (2013). Does the correspondence between EQ-5D health state description and VAS score vary by medical condition? Health and quality of life outcomes, 11(101153626), 155.CrossRefPubMedPubMedCentral
38.
go back to reference Korfage, I. J., Essink-Bot, M.-L., Westenberg, S. M., Helmerhorst, T., Habbema, J. D. F., & van Ballegooijen, M. (2014). How distressing is referral to colposcopy in cervical cancer screening?: a prospective quality of life study. Gynecologic Oncology, 132(1), 142–148.CrossRefPubMed Korfage, I. J., Essink-Bot, M.-L., Westenberg, S. M., Helmerhorst, T., Habbema, J. D. F., & van Ballegooijen, M. (2014). How distressing is referral to colposcopy in cervical cancer screening?: a prospective quality of life study. Gynecologic Oncology, 132(1), 142–148.CrossRefPubMed
40.
go back to reference Marcellusi, A., Capone, A., Favato, G., Mennini, F. S., Baio, G., Haeussler, K., et al. (2015). Health utilities lost and risk factors associated with HPV-induced diseases in men and women: The HPV Italian collaborative study group. Clinical Therapeutics, 37(1), 156–167. doi:10.1016/j.clinthera.2014.11.002.CrossRefPubMed Marcellusi, A., Capone, A., Favato, G., Mennini, F. S., Baio, G., Haeussler, K., et al. (2015). Health utilities lost and risk factors associated with HPV-induced diseases in men and women: The HPV Italian collaborative study group. Clinical Therapeutics, 37(1), 156–167. doi:10.​1016/​j.​clinthera.​2014.​11.​002.CrossRefPubMed
41.
go back to reference Lang, H.-C. (2012). Quality of life, treatments, and patients’ willingness to pay for a complete remission of cervical cancer in Taiwan. Health Economics. Lang, H.-C. (2012). Quality of life, treatments, and patients’ willingness to pay for a complete remission of cervical cancer in Taiwan. Health Economics.
42.
go back to reference Murasawa, H., Konno, R., Okubo, I., & Arakawa, I. (2014). Evaluation of health-related quality of life for hypothesized medical states associated with cervical cancer. Asian Pacific journal of cancer prevention: APJCP, 15(22), 9679–9685.CrossRefPubMed Murasawa, H., Konno, R., Okubo, I., & Arakawa, I. (2014). Evaluation of health-related quality of life for hypothesized medical states associated with cervical cancer. Asian Pacific journal of cancer prevention: APJCP, 15(22), 9679–9685.CrossRefPubMed
45.
go back to reference O’Connor, M., O’Leary, E., Waller, J., Gallagher, P., D’arcy, T., Flannelly, G., … Irish Cervical Screening Research Consortium (CERVIVA). (2015). Trends in, and predictors of, anxiety and specific worries following colposcopy: a 12-month longitudinal study. Psycho-Oncology. doi:10.1002/pon.3980. O’Connor, M., O’Leary, E., Waller, J., Gallagher, P., D’arcy, T., Flannelly, G., … Irish Cervical Screening Research Consortium (CERVIVA). (2015). Trends in, and predictors of, anxiety and specific worries following colposcopy: a 12-month longitudinal study. Psycho-Oncology. doi:10.​1002/​pon.​3980.
47.
go back to reference Heinonen, A., Tapper, A.-M., Leminen, A., Sintonen, H., & Roine, R. P. (2013). Health-related quality of life and perception of anxiety in women with abnormal cervical cytology referred for colposcopy: An observational study. European Journal of Obstetrics, Gynecology, and Reproductive Biology, 169(2), 387–391. doi:10.1016/j.ejogrb.2013.03.033.CrossRefPubMed Heinonen, A., Tapper, A.-M., Leminen, A., Sintonen, H., & Roine, R. P. (2013). Health-related quality of life and perception of anxiety in women with abnormal cervical cytology referred for colposcopy: An observational study. European Journal of Obstetrics, Gynecology, and Reproductive Biology, 169(2), 387–391. doi:10.​1016/​j.​ejogrb.​2013.​03.​033.CrossRefPubMed
48.
go back to reference Gray, N. M., Sharp, L., Cotton, S. C., Avis, M., Philips, Z., Russell, I., et al. (2005). Developing a questionnaire to measure the psychosocial impact of an abnormal cervical smear result and its subsequent management: The TOMBOLA (Trial of Management of Borderline and Other Low-grade Abnormal smears) trial. Quality of Life Research, 14(6), 1553–1562.CrossRefPubMed Gray, N. M., Sharp, L., Cotton, S. C., Avis, M., Philips, Z., Russell, I., et al. (2005). Developing a questionnaire to measure the psychosocial impact of an abnormal cervical smear result and its subsequent management: The TOMBOLA (Trial of Management of Borderline and Other Low-grade Abnormal smears) trial. Quality of Life Research, 14(6), 1553–1562.CrossRefPubMed
Metagegevens
Titel
Health-related quality of life as measured by the EQ-5D in the prevention, screening and management of cervical disease: A systematic review
Auteurs
A. Ó Céilleachair
J. F. O’Mahony
M. O’Connor
J. O’Leary
C. Normand
C. Martin
L. Sharp
Publicatiedatum
26-06-2017
Uitgeverij
Springer International Publishing
Gepubliceerd in
Quality of Life Research / Uitgave 11/2017
Print ISSN: 0962-9343
Elektronisch ISSN: 1573-2649
DOI
https://doi.org/10.1007/s11136-017-1628-z